Cognitive Leap

02/01/2025

Cognitive Leap is proud to announce the publication of a groundbreaking study titled "Normative Performance Data on Visual Attention in Neurotypical Children: Virtual Reality Assessment of Cognitive and Psychomotor Development" in the prestigious Frontiers in Virtual Reality journal. This innovative research sheds light on the potential of virtual reality (VR) technology in evaluating attention processes and cognitive development in children.

The study presents the results of the Virtual Reality Attention Test (VRAT) in assessing cognitive attention and psychomotor development in children across various metrics. Notably, the research highlights age progression and s*x differences in key variables, offering valuable insights for understanding cognitive and psychomotor development in children.

Furthermore, this research underscores the potential of VR technology, as utilized in Cognitive Leap's products, in providing a safe and ecologically valid environment for testing attention processes. VR's ability to mimic real-life challenges and capture users' behavioral responses offers a more systematic and objective approach to clinical assessment and intervention. This study marks a significant step forward in understanding and utilizing VR technology for healthcare applications, including the advancement of research on multiple sclerosis.

Frontiers in Virtual Reality, the journal in which the study is published, is an open-access, peer-reviewed academic journal known for its interdisciplinary approach to virtual reality research. In 2023, articles from Frontiers were viewed and downloaded over 687 million times worldwide, with a total of 7.2 million citations, highlighting the journal's significant impact on the academic and professional community.

Cognitive Leap is committed to continuing its research and development efforts in VR technology to revolutionize diagnostic and therapeutic approaches for children with attention-related disorders and to contribute to the advancement of research on multiple sclerosis.

03/01/2024

VRAT™ Advances to Substantive Review Stage in FDA 510(k) Application Process Irvine, CA – August 21, 2023

We are pleased to announce a significant milestone in the regulatory journey of VRAT™, as it has now entered the Substantive Review phase of the U.S. Food and Drug Administration’s (FDA) 510(k) application process for medical devices. The Virtual Reality Attention Tracker (VRAT™) is the first immersive VR-based digital assessment tool that combines cognitive and biometric data evaluation to improve the assessment of children and adolescents suspected of having ADHD. This advancement signifies that VRAT's application has successfully passed the initial Administrative Review (RTA Review) phase, confirming that the 510(k) submission package is comprehensive and includes all necessary items as per the FDA’s 510(k) checklist.

The commencement of the Substantive Review phase marks a critical step in the FDA’s thorough examination of VRAT’s application. During this phase, the FDA will conduct an in-depth analysis of all aspects of the submission package. This review is pivotal, as the FDA may request additional information or justification to ensure the application meets all regulatory standards and requirements.

The conclusion of the Substantive Review will lead to a final decision by the FDA regarding the approval status of VRAT™. We are committed to cooperating fully with the FDA throughout this process and are optimistic about the future prospects of VRAT™ in enhancing healthcare outcomes.

02/26/2024

🤝

Cognitive Leap and VRD HealthTech are partnering to expand solutions for attention assessment and management in children. Together, we're focused on improving focus, and so much more!

The Virtual Classroom Attention Tracker (vCAT) measures attention performance in children ages 6 to 13. Generates a comparative report within minutes.
The FocusEDTx app is a digital therapeutic solution that provides 60 animated sessions of content surrounding behavioral management in children, best suited for ages 6 to 12.

Learn more on our website, https://zurl.co/7fN7

02/03/2024